Key Takeaways
- • Apax Partners acquires two packaging businesses from Gerresheimer for €1.5 billion, comprising medical packaging firm Centor and a plastic packaging operation.
- • Combined 2025 revenue of €570 million across both businesses, with approximately 2,400 employees, indicating a mid-market platform consolidation in specialty packaging.
- • Transaction reflects private equity appetite for healthcare-adjacent packaging infrastructure, which benefits from recurring revenue streams tied to pharmaceutical and medical device supply chains.
- • Gerresheimer divests non-core packaging assets as part of portfolio optimization, allowing the parent company to refocus on core operations.
Summary
Apax Partners has agreed to acquire two packaging businesses from Gerresheimer—medical packaging firm Centor and a plastic packaging company—for a combined enterprise value of €1.5 billion. The transaction consolidates two complementary operations within the specialty packaging sector, a segment benefiting from structural tailwinds in pharmaceutical and medical device manufacturing.
The two businesses generated approximately €570 million in combined revenue during 2025 and employ around 2,400 people across their operations. The inclusion of Centor, a medical packaging specialist, alongside a broader plastic packaging business creates a diversified platform with exposure to both regulated healthcare packaging and general industrial applications. This combination allows Apax to build scale in a fragmented market while leveraging operational synergies across manufacturing, distribution, and customer relationships.
The transaction underscores ongoing private equity interest in healthcare-adjacent infrastructure assets, where recurring revenue from pharmaceutical supply chains and medical device packaging provides stable, contracted cash flows. Gerresheimer's decision to divest these operations suggests a strategic shift to focus on higher-margin or core competencies within its portfolio, a common strategy for industrial conglomerates seeking to optimize shareholder returns through focused operations.
The two businesses generated approximately €570 million in combined revenue during 2025 and employ around 2,400 people across their operations. The inclusion of Centor, a medical packaging specialist, alongside a broader plastic packaging business creates a diversified platform with exposure to both regulated healthcare packaging and general industrial applications. This combination allows Apax to build scale in a fragmented market while leveraging operational synergies across manufacturing, distribution, and customer relationships.
The transaction underscores ongoing private equity interest in healthcare-adjacent infrastructure assets, where recurring revenue from pharmaceutical supply chains and medical device packaging provides stable, contracted cash flows. Gerresheimer's decision to divest these operations suggests a strategic shift to focus on higher-margin or core competencies within its portfolio, a common strategy for industrial conglomerates seeking to optimize shareholder returns through focused operations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.